Cerevel Therapeutics Inc. (CERE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Cerevel Therapeutics Inc...

NASDAQ: CERE · Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 10:00 PM

Cerevel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
990.97M 136.52M 193.02M
Short-Term Investments
574.5M 755.51M 372.67M
Long-Term Investments
187.16M 58.13M 52.27M
Other Long-Term Assets
3.43M 4.76M 6.93M
Receivables
5.29M n/a 729K
Inventory
n/a -2.05M -729K
Other Current Assets
10.68M 13.62M 12.33M
Total Current Assets
1.01B 905.65M 578.02M
Property-Plant & Equipment
45.77M 49.29M 51.7M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
236.36M 112.17M 110.9M
Total Assets
1.24B 1.02B 688.92M
Account Payables
11.86M 10.06M 11.3M
Deferred Revenue
n/a n/a 28.43M
Short-Term Debt
3.4M 2.9M 2.44M
Other Current Liabilities
76.91M 59.6M 28.8M
Total Current Liabilities
92.18M 72.56M 42.54M
Long-Term Debt
365.21M 366.67M 34.11M
Other Long-Term Liabilities
112.16M 57.35M 33.54M
Total Long-Term Liabilities
477.37M 424.02M 67.65M
Total Liabilities
569.55M 496.58M 110.19M
Total Debt
480.78M 366.67M 36.55M
Book Value
673.75M 521.24M 578.73M
Book Value Per Share
4.16 3.45 4.24
Common Stock
18K 16K 15K
Retained Earnings
-1.4B -967.75M -616.24M
Comprehensive Income
1.77M 3.1M -986K
Shareholders Equity
673.75M 521.24M 578.73M
Total Investments
187.16M 813.63M 424.94M